BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bai X, Su G, Zhai S. Recent Advances in Nanomedicine for the Diagnosis and Therapy of Liver Fibrosis. Nanomaterials (Basel) 2020;10:E1945. [PMID: 33003520 DOI: 10.3390/nano10101945] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Hui Z, Li N, Zhang X, Liang L, Han D, Gong J, Li L, Li X. CoS nanosheets for generation of vector soliton and bound solitons in nonlinear optical fiber system. Optics & Laser Technology 2023;160:109026. [DOI: 10.1016/j.optlastec.2022.109026] [Reference Citation Analysis]
2 Li F, Zhao Y, Cheng Z, Wang Y, Yue Y, Cheng X, Sun J, Atabakhshi-Kashi M, Yao J, Dou J, Yu J, Zhang X, Qi Y, Li X, Qi X, Nie G. Restoration of Sinusoid Fenestrae Followed by Targeted Nanoassembly Delivery of an Anti-Fibrotic Agent Improves Treatment Efficacy in Liver Fibrosis. Adv Mater 2023;:e2212206. [PMID: 36862807 DOI: 10.1002/adma.202212206] [Reference Citation Analysis]
3 Xia S, Liu Z, Cai J, Ren H, Li Q, Zhang H, Yue J, Zhou Q, Zhou T, Wang L, Liu X, Zhou X. Liver fibrosis therapy based on biomimetic nanoparticles which deplete activated hepatic stellate cells. J Control Release 2023;355:54-67. [PMID: 36693527 DOI: 10.1016/j.jconrel.2023.01.052] [Reference Citation Analysis]
4 Xiang L, Wang X, Shao Y, Jiao Q, Cheng J, Zheng X, Zhou S, Chen Y. Folate Decoration Supports the Targeting of Camptothecin Micelles against Activated Hepatic Stellate Cells and the Suppression of Fibrogenesis. ACS Appl Mater Interfaces 2023;15:2030-42. [PMID: 36571106 DOI: 10.1021/acsami.2c16616] [Reference Citation Analysis]
5 Soares GA, Pereira GM, Romualdo GR, Biasotti GGA, Stoppa EG, Bakuzis AF, Baffa O, Barbisan LF, Miranda JRA. Biodistribution Profile of Magnetic Nanoparticles in Cirrhosis-Associated Hepatocarcinogenesis in Rats by AC Biosusceptometry. Pharmaceutics 2022;14:1907. [DOI: 10.3390/pharmaceutics14091907] [Reference Citation Analysis]
6 Comanescu C. Magnetic Nanoparticles: Current Advances in Nanomedicine, Drug Delivery and MRI. Chemistry 2022;4:872-930. [DOI: 10.3390/chemistry4030063] [Reference Citation Analysis]
7 Li W, Liu W, Qian D, Liu J, Zhou S, Zhang L, Peng W, Su L, Zhang H. Traditional Chinese medicine: An important source for discovering candidate agents against hepatic fibrosis. Front Pharmacol 2022;13:962525. [DOI: 10.3389/fphar.2022.962525] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Adetunji CO, Michael OS, Rathee S, Singh KR, Ajayi OO, Adetunji JB, Ojha A, Singh J, Singh RP. Potentialities of nanomaterials for the management and treatment of metabolic syndrome: A new insight. Materials Today Advances 2022;13:100198. [DOI: 10.1016/j.mtadv.2021.100198] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
9 El Awdan SA, F. Asaad G. Liver Fibrosis: Underlying Mechanisms and Innovative Therapeutic Approach. A Review Article. Biomed Pharmacol J 2021;14:1841-1862. [DOI: 10.13005/bpj/2283] [Reference Citation Analysis]
10 Xu Y, Chen J, Jiang W, Zhao Y, Yang C, Wu Y, Li Q, Zhu C. Multiplexing Nanodrug Ameliorates Liver Fibrosis via ROS Elimination and Inflammation Suppression. Small 2021;:e2102848. [PMID: 34758098 DOI: 10.1002/smll.202102848] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
11 Medrano-Bosch M, Moreno-Lanceta A, Melgar-Lesmes P. Nanoparticles to Target and Treat Macrophages: The Ockham's Concept? Pharmaceutics 2021;13:1340. [PMID: 34575416 DOI: 10.3390/pharmaceutics13091340] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
12 Sofias AM, De Lorenzi F, Peña Q, Azadkhah Shalmani A, Vucur M, Wang JW, Kiessling F, Shi Y, Consolino L, Storm G, Lammers T. Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders. Adv Drug Deliv Rev 2021;175:113831. [PMID: 34139255 DOI: 10.1016/j.addr.2021.113831] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
13 Gilgenkrantz H, Mallat A, Moreau R, Lotersztajn S. Targeting cell-intrinsic metabolism for antifibrotic therapy. J Hepatol 2021;74:1442-54. [PMID: 33631228 DOI: 10.1016/j.jhep.2021.02.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
14 Peng W, Cheng S, Bao Z, Wang Y, Zhou W, Wang J, Yang Q, Chen C, Wang W. Advances in the research of nanodrug delivery system for targeted treatment of liver fibrosis. Biomedicine & Pharmacotherapy 2021;137:111342. [DOI: 10.1016/j.biopha.2021.111342] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
15 Ryabchikova E. Advances in Nanomaterials in Biomedicine. Nanomaterials (Basel) 2021;11:E118. [PMID: 33430171 DOI: 10.3390/nano11010118] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]